{"docid":"VWS-WC-025-2","collapsed":true,"count":1,"unchecked":0,"snapshots_total":3,"versions":[{"archive_id":"folder_import_71034_3f2cce63b8afcee36bbae9b3fe984912","bestandsnaam":"VWS-WC-025-2.pdf","created_date":"2025-09-07 17:31:23","last_seen":"2025-09-07 17:31:23","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WC-025-2.pdf","snippet":"1Van: Lucas Wiarda @innogenerics.com>\nVerzonden: donderdag 5 december 2019 15:49\nAan:\nOnderwerp: Concept memo PPS Innogenerics mbt Apotex NL\nBijlagen: Memo_Innogenerics toont interesse in Apotex NL_DR","digest":"2c73928dbaca","dupes":3,"date_to":"2025-09-07 17:31:23","date_from":"2025-02-18 12:18:02","unchecked":false}],"raw":[{"archive_id":"folder_import_71034_3f2cce63b8afcee36bbae9b3fe984912","bestandsnaam":"VWS-WC-025-2.pdf","created_date":"2025-09-07 17:31:23","last_seen":"2025-09-07 17:31:23","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WC-025-2.pdf","snippet":"1Van: Lucas Wiarda @innogenerics.com>\nVerzonden: donderdag 5 december 2019 15:49\nAan:\nOnderwerp: Concept memo PPS Innogenerics mbt Apotex NL\nBijlagen: Memo_Innogenerics toont interesse in Apotex NL_DR","digest":"2c73928dbaca"},{"archive_id":"VWS-WC-025-1f026c98-6e09-61ca-ba51-65673e0af118.zip_2","bestandsnaam":"VWS-WC-025-2.pdf","created_date":"2025-09-04 16:12:27","last_seen":"2025-09-04 16:12:27","from_file":"VWS-WC-025-1f026c98-6e09-61ca-ba51-65673e0af118.zip","bron":"../../archieven_files/VWS-WC-025-1f026c98-6e09-61ca-ba51-65673e0af118.zip","snippet":"1Van: Lucas Wiarda @innogenerics.com>\nVerzonden: donderdag 5 december 2019 15:49\nAan:\nOnderwerp: Concept memo PPS Innogenerics mbt Apotex NL\nBijlagen: Memo_Innogenerics toont interesse in Apotex NL_DR","digest":"2c73928dbaca"},{"archive_id":"30539","bestandsnaam":"VWS-WC-025-2-Concept_memo_PPS_Innogenerics_mbt_Apotex_NL.pdf","created_date":"2025-02-18 12:18:02","last_seen":"2025-02-18 12:18:02","from_file":"besluit-025-16214a053578ee8dba87c80afa18e1154be5aa5c081fbaf0f978cc9887c638be.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\besluit-025-16214a053578ee8dba87c80afa18e1154be5aa5c081fbaf0f978cc9887c638be.zip","snippet":"1Van: Lucas Wiarda @innogenerics.com>\nVerzonden: donderdag 5 december 2019 15:49\nAan:\nOnderwerp: Concept memo PPS Innogenerics mbt Apotex NL\nBijlagen: Memo_Innogenerics toont interesse in Apotex NL_DR","digest":"2c73928dbaca"}],"filename":"Concept memo PPS Innogenerics mbt Apotex NL","truncated":false,"elapsed_ms":2}